Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (1y) (2014 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | -117.27% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | -367.42% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | 34.03% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -514.66% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | -3.47% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -27.08% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 1,005.12% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,005.12% |
| Mar 31, 2026 | -97.10% |
| Dec 31, 2025 | -13.79% |
| Sep 30, 2025 | 1,017.85% |
| Jun 30, 2025 | 141.40% |
| Mar 31, 2025 | -45.47% |
| Dec 31, 2024 | 67.93% |
| Sep 30, 2024 | -97.86% |
| Jun 30, 2024 | 54.95% |
| Mar 31, 2024 | 177.79% |
| Dec 31, 2023 | -10,738.45% |
| Sep 30, 2023 | 1,459.14% |
| Jun 30, 2023 | -301.76% |
| Mar 31, 2023 | -55.72% |
| Dec 31, 2022 | -105.89% |
| Sep 30, 2022 | 50.18% |
| Jun 30, 2022 | -128.00% |
| Mar 31, 2022 | 518.12% |
| Dec 31, 2021 | 340.78% |
| Sep 30, 2021 | -5,461.21% |